The most well-evidenced benefit of ACV is its ability to attenuate post-meal blood glucose spikes. Acetic acid appears to inhibit disaccharidase enzymes in the small intestine, slowing the digestion of starches and reducing the rate at which glucose enters the bloodstream. It may also improve insulin sensitivity in peripheral tissues. A 2023 meta-analysis of 25 controlled clinical trials (PMID 37608660) found that ACV significantly reduced fasting blood sugar by approximately 21 mg/dL and HbA1c by 0.91% in people with type 2 diabetes or prediabetes. Effects were dose-dependent, with greater reductions at doses exceeding 10 mL per day. A 2019 RCT in patients with type 2 diabetes and dyslipidemia found improvements across multiple glycemic markers, including HOMA-IR and oxidative stress indices, after 8 weeks of daily consumption. Effects in healthy individuals without glucose dysregulation are more modest.
Some clinical trials report modest reductions in body weight, waist circumference, and body fat with regular ACV consumption. The proposed mechanism involves acetic acid promoting satiety, slowing gastric emptying, and reducing the caloric contribution of starchy foods. A 2025 GRADE-assessed systematic review and meta-analysis of 10 RCTs (789 participants) found that daily ACV intake significantly reduced body weight, waist circumference, and body fat, with dose-dependent effects at intakes above 10 mL/day. Effect sizes were modest, typically 1–3 kg over 12 weeks. A 2025 GRADE meta-analysis on glycemic control (PMC 11821484) confirmed fasting blood glucose reductions of roughly 22 mg/dL and an HbA1c reduction of 1.53% in type 2 diabetes patients, corroborating the earlier 2023 meta-analysis. ACV is not a substitute for caloric restriction or exercise.
Acetic acid is a well-established antimicrobial agent, it is the reason vinegar has been used as a food preservative for millennia. In vitro studies demonstrate that ACV inhibits the growth of pathogens including E. coli and Staphylococcus aureus. However, these concentrations may not be meaningfully replicated in the gut after oral consumption. The gut microbiome effects of regular ACV intake in humans are not well characterized.
ACV is highly acidic (pH ~3) and should always be diluted in water (1–2 tablespoons per 250 mL) before drinking. Undiluted consumption can damage tooth enamel and irritate the esophagus with repeated use. ACV interacts with medications that affect blood sugar (insulin, sulfonylureas) and potassium levels. Topical application for skin conditions can cause chemical burns in sensitive individuals.